Top Markets
#1 Wibx Wibx +8.04%
#2 Status Status +7.32%
#3 Decred Decred +5.88%
#4 aelf aelf +5.13%
#5 Humanity Humanity +4.81%
#6 MarsCoin MarsCoin +3.34%
#7 TRIA TRIA +3.25%
#8 Rei Rei +2.83%
#9 Bless Bless +2.73%
#10 rsERG rsERG +2.41%
Coin of the day
Wibx Wibx
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Finch Therapeutics Group, Inc. Finch Therapeutics Group, Inc.

Finch Therapeutics Group, Inc.

FNCH
Rang in Aktien #30543
Finch Therapeutics is a microbiome technology company with a portfolio of... Finch Therapeutics is a microbiome technology company with a portfolio of intellectual property and microbiome assets. The company is now focused on realizing the value of its intellectual property estate and other assets, while supporting the advancement of its microbiome technology through partnerships and collaborations after winding down development efforts.
Aktienkurs
$10.20
Zuletzt synchronisiert: 2026-08-05
Marktkapitalisierung
$16.38M
Veränderung (1 Tag)
2.00%
Veränderung (1 Jahr)
-18.40%
Land
US
Handel Finch Therapeutics Group, Inc. (FNCH)

Kategorie

Healthcare
Dividendenrendite-Verlauf für Finch Therapeutics Group, Inc. (FNCH)
Dividendenrendite (TTM) von Finch Therapeutics Group, Inc. (Aktienkürzel: FNCH) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für Finch Therapeutics Group, Inc. (FNCH) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber
Unternehmen Dividendenrendite Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
0.48%
BE